Noble

What Noble does

Noble International, LLC is a privately held pharmaceutical services company and wholly-owned subsidiary of Aptar Pharma that develops patient training devices and onboarding programs for self-administered combination products. Founded in the early 1990s and headquartered in Orlando, Florida, Noble operates a portfolio spanning six physical training device categories (autoinjector, prefilled syringe, nasal, onbody/wearable, pulmonary, and accessories) plus three service pillars: Clinical Training Enablement for healthcare providers, User Experience Services covering human factors engineering and design research, and Home Education and Practice combining physical kits with digital reinforcement. Its flagship SureStartRx program delivers training kits through specialty pharmacy distribution alongside a patient's first dose to address early therapy discontinuation.

Underlying technology centers on proprietary needle simulation (Encased and Agitator options), resettable mechanism designs that allow repeated training use, multisensory actuation feedback replicating auditory and haptic device cues, and nasal simulation platforms co-developed with Aptar Pharma. Smart features including Bluetooth connectivity, sensors, audio cues, and error detection appear on onbody and pulmonary training devices. Noble operates global usability labs with realistic home and clinical environments, and reports 30,000+ cumulative research hours and 40+ regulatory UX/human factors studies completed in 2024 alone.

Noble monetizes through a mix of hardware sales (physical training devices), professional services (UX research, human factors engineering, device design), licensing and OEM partnerships (co-branded training devices for SHL, BD, Ypsomed, Owen Mumford, Nemera, Aptar Pharma, Enable), and bundled onboarding program fees via SureStartRx. Pricing is quote-based under multi-year contracts. Go-to-market combines direct enterprise field sales to pharmaceutical manufacturers, drug device OEMs, and MedTech innovators with channel distribution through specialty pharmacy partners for SureStartRx. Thought leadership and brand awareness are built through content marketing, industry events (PanAgora, Asembia), and podcast appearances.

Name

Noble

Legal name

Noble International, LLC

Website

https://gonoble.com

Company type

Private

Founded year

1990

Operating status

Operating

Headcount range

11–50 employees

Short description

Noble International is an Aptar Pharma subsidiary that develops patient training devices and onboarding programs for self-administered combination products, serving pharmaceutical manufacturers, specialty pharmacies, drug device OEMs, and MedTech innovators across six delivery modalities.

Ownership category

akta.pro rank

Product category

Patient Training Devices and Human Factors Services

NAICS

Surgical and Medical Instrument Manufacturing (339112), Scientific Research and Development Services (5417)

SIC

Surgical & Medical Instruments & Apparatus (3841)

akta.pro primary industry

Auto-Injectors (Disposable & Reusable) (HLAHAIAB)

akta.pro secondary industries

Wearable Injectors & On-Body Delivery Systems (HLAHAIAE), Drug Delivery Connectivity, Sensors & Digital Add-Ons (Smart Caps/Companion Apps) (HLAHAIAM), Connected Therapeutics & Smart Drug Delivery Monitoring (HLACAFAL), Specialty Pharmacy & Complex Therapy Management Platforms (HLACAKAG)

Keywords

• Patient training devices
• Drug delivery training
• Human factors engineering
• Pharmaceutical patient onboarding
• Medication adherence solutions

Headquarters

HQ city

Orlando

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Technology or R&D, Infrastructure, Operations, Marketing or Sales, Supply Chain

Revenue model

1. Training Device Sales (Physical Products): Noble sells physical training and demonstration devices (autoinjectors, prefilled syringes, nasal, onbody, pulmonary, accessories) to pharmaceutical companies, drug device manufacturers, and specialty pharmacies. Devices are available as both platform (pre-configured) and custom solutions. Revenue is generated through product sales, likely under multi-year contracts or per-unit pricing.
2. SureStartRx Program (Patient Onboarding Services): SureStartRx is a specialty pharmacy-led onboarding program that pairs pharmaceutical manufacturers with specialty pharmacies at the point of first dose. Includes training kits with demonstration devices and digital support, delivered through specialty pharmacy distribution.
3. User Experience Services: UX research, human factors engineering, industrial design, and regulatory strategy services delivered to pharmaceutical and MedTech companies across the product lifecycle. Includes formative and summative human factors studies, device strategy and development, and evidence and claims generation.
4. Device Design and Development Services: Bespoke device development services from early discovery through concept iteration and refinement, platform evaluation and selection, and manufacturing guidance for drug delivery devices.
5. Licensing and OEM Training Device Partnerships: Noble develops and provides branded training devices in partnership with drug device manufacturers (e.g., SHL Molly, BD Physioject, YpsoMate, Owen Mumford Aidaptus, BD Intevia, Aptar Pharma Unidose/Bidose, Nemera Safe'n'Sound, BD UltraSafe Plus). These are co-branded training products.

Pricing tiers

Go-to-market motion3 records

Distribution channels3 records

Marketing channels5 records

Core offering

Noble designs, manufactures, and distributes physical patient training and demonstration devices for self-administered drug delivery systems, including autoinjectors, prefilled syringes, nasal, onbody (wearable injectors), pulmonary inhalers, and supporting accessories. The company complements these devices with human factors engineering, UX research, and device design services, and orchestrates the flagship SureStartRx specialty pharmacy-led patient onboarding program that pairs training kits with a patient's first dose. The portfolio is built on over 30 years of human factors expertise and backs 120+ global therapy launches.

Product overview

Noble provides an integrated portfolio of patient training and onboarding solutions designed to build confidence, improve adherence, and drive better therapy outcomes. The core offering centers on realistic training devices across six delivery modalities: Autoinjector, Prefilled Syringe, Nasal, Onbody (wearable injector), Pulmonary (inhaler), and Accessories. These physical devices are complemented by three key service pillars: Clinical Training Enablement (supporting healthcare providers with demo tools), User Experience Services (human factors, design research, and ergonomic expertise), and Home Education and Practice (combining physical kits with digital reinforcement for patient self-training). The flagship program SureStartRx orchestrates these capabilities into a specialty pharmacy-delivered onboarding solution that pairs training kits with the first dose to reduce early drop-off and accelerate refill behavior. The portfolio is built on over 30 years of human factors expertise and is backed by Aptar Pharma's manufacturing standards and digital health capabilities.

Differentiator

Problem solved

Functional benefit

Products and services

• Autoinjector Training Devices Platform and custom autoinjector training devices designed to replicate the true feel and experience of self-injection, featuring reset functionality, customizable plunger speed, and actuation simulation for hands-on patient training. Sold to pharmaceutical manufacturers, drug device manufacturers, and specialty pharmacies.
• Prefilled Syringe Training Devices Platform and custom prefilled syringe training devices featuring proprietary needle simulation technology (Encased and Agitator options) designed to replicate the actual treatment experience, reduce needle anxiety, and boost user confidence.
• Nasal Training Devices Nasal training device platforms co-developed with Aptar Pharma featuring proprietary simulation technology that replicates actual nasal delivery systems (Unidose liquid/powder, Bidose) in form and function for realistic emergency preparedness training.
• Onbody Training Devices Wearable injector training devices that simulate attributes of actual onbody devices including resettable mechanical systems and smart features such as Bluetooth connectivity, sensors, audio cues, error detection/correction, replaceable adhesives, and cartridge simulation.
• Pulmonary Training Devices Pulmonary training devices that simulate attributes of actual MDIs and DPIs, providing realistic training experiences with actuation force simulation, reusable designs, and optional smart features including Bluetooth connectivity, sensors, audio cues, and error detection/correction.
• Training Device Accessories Customizable premium packaging and travel kits designed to support, protect, and elevate the training experience, with temperature control options for medications requiring specific storage conditions.
• Clinical Training Enablement Services providing healthcare providers with realistic demonstration devices and training support to ensure consistent, compliant, and clear patient education for confident therapy starts.
• User Experience Services Human-centered design and ergonomic science services including device strategy, evidence generation, human factors engineering, and design research to build safer, more intuitive solutions that meet regulatory expectations. 70+ UX Services employees across two sites with 30,000+ hours of global research performed.
• Home Education and Practice Home-based training solutions combining physical training kits with digital reinforcement to help patients understand therapy, build confidence in self-administration, and use devices correctly in real-world settings.
• SureStartRx Patient onboarding program that delivers realistic training devices and guided digital support through specialty pharmacy partnerships to protect therapy initiations, strengthen early persistence, and ensure successful first-dose experiences. Distributed through specialty pharmacies with kits shipped alongside the first dose.

Quantifiable outcome

• 38% improvement in time to first injection, enabled by patient training and support programs
• +6 more outcomes

Named customers3 records

Segments4 records

Ideal customer profiles4 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature8 records

Partnerships

Twelve partnerships are on record, tiered core, strategic and minor.

• Aptar PharmacoreStrategic or Co-development PartnerNoble is an Aptar Pharma company operating within the Aptar Pharma family. This parent-subsidiary relationship provides Noble with Aptar's financial strength, manufacturing standards, and digital expertise. Noble leverages Aptar's resources and brand credibility to deliver differentiated patient training and engagement solutions.
• Aptar Digital HealthcoreTechnology or IntegrationAptar Digital Health (ADH) provides digital companion apps that complement Noble's physical training devices. ADH apps connect early onboarding with ongoing education, provide always-on access to guidance and support resources, and extend patient engagement without increasing operational burdens. Noble recommends ADH apps as the digital layer for home training programs.
• YpsomedcoreChannel Partner/ Reseller/ DistributorYpsomed is a drug delivery device manufacturer whose YpsoMate autoinjector platform is supported by Noble's YpsoMate Training Devices. Noble provides branded training devices for Ypsomed's drug delivery platforms, enabling pharmaceutical customers to offer realistic training alongside Ypsomed devices.
• BD (Becton, Dickinson and Company)coreChannel Partner/ Reseller/ DistributorBD partners with Noble to offer BD Physioject and BD Intevia demonstration devices through Noble's training platform. Noble has also developed BD UltraSafe Plus and Passive Needle Guard demonstration devices. This enables BD to provide comprehensive training support alongside its drug delivery devices.
• Owen MumfordcoreChannel Partner/ Reseller/ DistributorOwen Mumford's Aidaptus autoinjector is supported by Noble's Aidaptus Training Device. Noble develops custom training devices that replicate the Aidaptus platform's unique dual-chamber syringe capability, allowing pharmaceutical customers to offer realistic hands-on training.
• NemeracoreChannel Partner/ Reseller/ DistributorNemera's Safe'n'Sound prefilled syringe safety system is supported by Noble's Safe'n'Sound Training Device. Noble's training device replicates the device's safety and shielding systems with a proprietary resettable locking needle guard for repeated training use.
• SHL Medical (SHL Molly)coreChannel Partner/ Reseller/ DistributorSHL Medical's Molly autoinjector platform is supported by Noble's Molly Training Devices. Noble's training device replicates all aspects of the actual device in form and function, including customizable plunger speed, actuation simulation, resettable mechanism, and agitator needle simulation.
• Aptar Pharma (Nasal Programs)coreStrategic or Co-development PartnerNoble and Aptar Pharma together developed a variety of nasal training device platform programs featuring proprietary simulation technology. Aptar Pharma's Unidose (liquid and powder) and Bidose nasal delivery systems are supported by Noble's corresponding training devices.
• Enable InjectionsstrategicStrategic or Co-development PartnerAptar Digital Health and Enable Injections announced a collaboration to signal the next evolution of patient-centered combination products. Noble, as part of Aptar Pharma, is positioned to support this evolution with training and patient engagement solutions for onbody injection platforms.
• West Pharmaceutical ServicesminorChannel Partner/ Reseller/ DistributorWest Pharmaceutical Services logo appears in the drug delivery manufacturing partners section on Noble's website, indicating a collaborative relationship in the training device ecosystem.
• Enable (Enable Injections)minorChannel Partner/ Reseller/ DistributorEnable logo appears in the drug delivery manufacturing partners section on Noble's website alongside other established device manufacturers, indicating a collaborative training device partnership.
• PanAgora (Pharma CX Summit)minorGTM or Marketing PartnerNoble participated in the PanAgora Pharma CX Summit with a speaking panel on patient experience. Adam Shain, VP and Head of Business Transformation at Noble, spoke alongside leaders from Celltrion USA and Harmony Biosciences, building thought leadership and brand awareness.

Scale indicators16 records

Recent moves6 records

Expansion highlights7 records

Direct peers

• Worrell: Worrell is a product design and development firm with a dedicated medical device and drug delivery practice. It competes with Noble on user-centered device design, human factors validation, and patient training programs for self-administered therapies.
• Key Tech: Key Tech is a medical device engineering and human factors firm that develops combination products and conducts usability engineering for pharma sponsors. It directly overlaps with Noble's device development and regulatory human factors service lines.
• Emergo by UL: Emergo by UL provides human factors engineering, usability testing, and regulatory consulting for medical devices and combination products. It directly overlaps with Noble's UX Services and human factors regulatory submission work for pharma and MedTech clients.
• HS Design: HS Design is a medical device design and human factors engineering consultancy that helps pharma and MedTech clients develop, validate, and submit combination products — directly comparable to Noble's UX Services and regulatory evidence offerings.
• Interface Analysis Associates: Interface Analysis Associates is a specialist human factors and usability engineering consultancy serving medical device and pharmaceutical companies. It competes with Noble on human factors studies, label and IFU testing, and combination product submissions.
• Ximedica: Ximedica is a medical device development and human factors engineering firm serving pharma and MedTech customers. It competes with Noble's device strategy, design research, and human factors engineering services for combination products.
• Shirley Ryan AbilityLab (formerly RIC) / DesignWorks Medical: Not a direct match; replaced below.

Others

• SHL Medical: SHL Medical is a major drug delivery device manufacturer behind the Molly autoinjector platform. Noble currently co-brands Molly training devices with SHL, but SHL's ownership of the underlying platform makes it both a key partner and a strategic counterpart that could expand into adjacent training services.
• Aptar Pharma: Aptar Pharma is Noble's parent company and a global supplier of drug delivery systems, dispensing components, and active material solutions. As the parent and ecosystem partner, Aptar Pharma provides Noble with manufacturing scale, digital health integration, and access to global pharma accounts — making it the most economically significant relationship in Noble's peer set.
• Ypsomed: Ypsomed is a leading independent manufacturer of injection and infusion systems, including the YpsoMate autoinjector. While Noble currently partners with Ypsomed on branded training devices, Ypsomed could choose to internalize or source training elsewhere, making it both a critical channel partner and a potential competitor.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat7 records

Key risks5 records

Key highlights6 records

Customer concentration

• Xx.com/noblepharma
• Facebookfacebook.com/NobleInternationalInc

Revenue estimate

Valuation estimate

Number of profiles

Profiles5 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A1 record

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Noble